Stocks-CRL-Charles River Laboratories International Inc

CRL Charles River Laboratories International Inc

0 0 (0%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: Charles River Laboratories International Inc's revenues increased by 12.31% and amounted to 3.98B. Net income increased by 23.51% to 492.61M. Net assets increased by 16.65% to 3.02B and EPS increased from 7.60 to 9.48.
CRL's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
33.17%
Net Profit Margin
11.34%
Operating Margin
15.40%
Return On Investment
7.71%